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A B S T R A CT  
Schizophrenia is one of the 15 leading causes of disability worldwide. About 1% of the global 
population has schizophrenia, with 10% of premature mortality chance. Schizophrenia is therefore 
associated with significant health, social and economic concerns. In this context, thalamus and striatum 
areas play important roles as much in schizophrenia as processing information before reaching the 
conscious thought: step happening soon in the creativity action. Creativity is defined by psychological 
scientists as the generation of ideas or products that are both original and valuable. Creativity relies on 
imagination and this fundamental human ability remains understudied in comparison to other 
important psychological phenomena. It is natural to ask whether the gene expression profiling of 
samples from schizophrenic patients could highlight the activity of some genes specific to humans. 
Microarray analysis of the dataset GSE25673 revealed that the pseudogene RNU6-505P is 
expressed differentially in schizophrenic samples and correlates to CYP26A1, ARHGAP18, 
TSPAN12, HEY2 and TMEM132A genes. Ontological analysis showed that the RNU6-505P 
pseudogene is involved in brain development and certain neurological pathologies. Evolutionary 
analysis showed that the AGA 3-nucleotide sequence of RNU6-505P has been under positive selective 
pressure. Finally, the 1-nucleotide mutation prediction test revealed that variations on the AGA 
nucleotides could be fatal to the RNA structure of the sequence. We conclude that differential 
expression of the RNU6-505P pseudogene can be valid to diagnose schizophrenia and the RNU6-505P 
pseudogene may have a relevant function in the cerebral development and in the divergent evolution 
of humans from apes. 
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1 Introduction  
Finding a starting point that suggests how the 
human being has differentiated from common 
ancestors with apes is certainly a very fascinating 
and complex topic. The innate abilities to create 
and imagine are the prerogatives of the human 
species. Creativity (to create art, invent tools, 
think scientifically, etc.) is a remarkable 
activity normally operated by humans. And this, 
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at least as far as we know at the moment, could 
distinguish the human species from its ancestors 
and close relatives. The investigation into the 
origins of human creativity may provide 
important information about the evolutionary 
process. Previous works [1-3] have tried to find a 
relationship between the state of "madness" and 
"creativity". On the other hand, regions of the 
brain (e.g., the striatum and the thalamus) are 
principal actors both in information processing 
before it reaches the state of consciousness (soon 
step of creative activity) and in the case of 
patients with schizophrenia. Through the 
investigations of the anatomy of the brains of 
primates [4], the nature of the interconnected 
tissues of the cerebellum to the multiple motor 
cortices suggested that the thalamus fulfills a key 
function in providing the specific channels from 
the basal ganglia and cerebellum to the cortical 
motor areas. 
Differential gene expression in schizophrenia 
brain cells may elucidate which genes might be 
involved in disease progression, such as those 
that are expressed statistically differently in 
schizophrenia patients [5].  One GWAS study 
showed that 185 genes may have associations 
with schizophrenia [6].  The involved genes may 
be up- or down-regulated depending on a stage 
of disease [7]. Some recent studies on increased 
pseudogene expression in schizophrenia-derived 
cell lines showed that the NDUFV2P1 
pseudogene contributes to mitochondrial 
complex I deficits [8].  
In this study, we hypothesized that genetic 
analysis of schizophrenia may lead to clues to the 
evolutionary process of human and estimated 
possible selective pressures on specific 
nucleotides of samples from schizophrenic 
patients, using the RNU6-505P pseudogene as a 
marker for schizophrenia, with a focus on its 
postulated activity in the development of the 
human brain and involvement in different brain 
functions/diseases. The selective pressures on a 
specific region preceding the RNU6-505P 
pseudogene containing the AGA sequence seems 
to be related to its secondary structure, suggesting 
that RNU6-505P may have played important 
roles in the human evolutionary process. 
2 Materials and Methods 
2.1 Differential Cluster Analysis 
We started the research with the microarray 
analysis of the dataset GSE25673 [9], comparing 
control and schizophrenic hiPSC-derived 
neurons.  In order to be sure about the quality of 
the information, we conducted all the preliminary 
steps using the Oligo [10] package into 
Bioconductor 3.4 [11]. As could be seen in Figure 
1, the arrays are nicely centered around Relative 
Log Expression (RLE), with approximately equal 
box sizes and no quality control problems. From 
the Normalized Unscaled Standard Error 
(NUSE), it appears that the arrays are reasonably 
centered around the median (NUSE = 1) and but 
do not appear to present any quality control 
{Emilio: please change it back if my “correction” 
was not correct}. Applying the RMA (robust 
multichip average) background adjustment, 
normalization and summarization, we observe 
(Figure 2) that the boxplots of all arrays are nicely 
aligned (A) and that the low regression line (B) 
provides an evidence that the applied procedures 
were adequate.  
Then we used Limma [12] package to calculate a 
moderated t-statistic with shrunken standard 
deviation for each gene. An empirical Bayes 
method was used to shrink the variance of each 
gene towards a common value for all the genes. 
Note that this has done to lower the influence of 
very low or very high standard deviations on the 
t-test. The subsequent cluster analysis, has been 
conducted using the mclust [13] package.
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Figure 1: RLE and NUSE boxplots after the RMA 
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Figure 2: Boxplots and MA plot after the RMA 
2.2 Correlation Analysis 
Limma package was also used to calculate the 
Pearson correlation. We utilized RPISeq tool [14] 
to estimate the goodness of the interaction 
between the RNU6-505P pseudogene and its 
correlated genes. This method, based on 
machine-learning approach, can readily predict 
RNA-protein interactions using only sequence 
information. RPISeq predictions are based on 
Random Forest (RF) or Support Vector Machine 
(SVM) classifiers trained and tested on 2 non-
redundant benchmark datasets of RNA-protein 
interactions, RPI2241 and RPI369, extracted 
from PRIDB [15]. Also, we used the NCBI 
BLAST tool to make comparative analysis [16]. 
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2.3 Gene Network and Ontological 
Analysis 
In order to obtain an exhaustive gene network 
concept, we preliminarily used GeneAnswers [17] 
package for investigating the functions assumed 
by the genes correlated to RNU6-505P. Since we 
worked with the EGAN tool [18] on Entrez 
Human Dataset [19] to collect information from 
all available genes-functions-ontology databases. 
We addressed OMIM [20] to investigate the 
pathologies where “correlated” genes are 
involved. ATLAS database [21] has accessed to 
get the expression level of genes in prenatal 
human brain.  
2.4 Evolutionary Analysis 
Ete3 [22] toolkit (based on CodeML program 
from PAML package [23]) supported the research 
of selective pressure defined by the ratio dN/dS 
(synonymous rate/non-synonymous rate). We 
considered the 345bp sequence (119bp before 
and after the RNU6-505P pseudogene) of 
human, chimpanzee, gorilla and mouse.  We 
applied the bsA1 as null model and bsA as 
alternative model (different dN/dS) for testing 
the positive pressure on sites on specific branches 
[24-26].  
2.5 Secondary Structure Mutation 
Prediction  
Prediction of the secondary structure of RNU6-
505P “extended” sequence (345bp) has obtained by 
RNAFold [27] program. The same tool was used 
to calculate the secondary structure of the 
“extended” RNU6-505P pseudogene in case of 
single nucleotide mutation. 
3 Results and Discussion 
3.1 Differential Expression of RNU6-
505P and Cluster Analysis 
Differential analysis of the dataset revealed that 
RNU6-505P belongs to the subset of genes 
whose 𝑙𝑜𝑔𝐹𝐶 > 2 , as we can see by the volcano 
plot in Figure 3 RNU6-505P looks up regulated 
same as other genes in the red cluster. In fact, 
taking in consideration the top 100 genes sorted 
by the adjusted  
Figure 3. Volcano plot of the dataset. In red colour are genes in CL5; dashed red lines indicate up and down 
regulated genes; also, the black line with 𝑝 < 10−5 is shown. 
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P value, cluster analysis shown (Figure 4) that 
63% of them belong to a small (568 of 33297) 
group (CL5). As we can see by the coming short 
Table 1, the highlighted genes have 
adjusted P value ≤ 1.2𝐸−0.5 and all of them 
show a higher level of differential expression on 
schizophrenic patients, such that they are placed 
in the “erupting” portion of the volcano diagram 
(Figure 3).  
Table 1: Adjusted P values of the top 20 genes 
SYMBOL Adj.P.Value Cluster 
CHST9 2.5E-0.7 CL5 
PDE4D 2.E-0.7 CL5 
C4B 1.2E-0.6 CL5 
NET1 1.5E-0.6 CL5 
GLI3 1.5E-0.6 CL5 
ZIC1 1.6E-0.6 CL5 
SLC34A2 1.6E-0.6 CL5 
CYP26A1 1.8E-0.6 CL5 
TSPAIN2 1.8E-0.6 CL5 
PRCP 1.9E-0.6 Not CL5 
ALDH1L1 2.0E-0.6 CL5 
S100A16 3.5E-0.6 CL5 
UCP2 6.8E-0.6 Not CL5 
PRDM8 7.8E-0.6 Not CL5 
WASF2 7.8E-0.6 Not CL5 
MATN2 7.8E-0.6 CL5 
HEY2 7.8E-0.6 CL5 
KCND3 8.1E-0.6 CL5 
ARAP2 1.2E-0.5 CL5 
Figure 4: Distribution of the top 100 genes over 5 
clusters 
3.2 Correlation of RNU6-505P to Specific 
Genes 
In attempt to conceive a valid hypothesis about 
the probable rule carried out by the RNU6-505P 
gene, we calculated the Pearson correlation and 
its relative significance for all genes in CL5. The 
Table 2 shows the list of the top genes with 
𝑃𝑒𝑎𝑟𝑠𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 𝑜𝑓 𝑐𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛 ≥
|0.76|  (positive and negative) and 
𝑃𝑒𝑎𝑟𝑠𝑜𝑛 𝑠𝑖𝑔𝑛𝑖𝑓𝑖𝑐𝑎𝑛𝑐𝑒 ≤ |5.97𝐸−0.05| . 
Reporting the best 5 genes (up/down regulated) 
on the volcano plot (Figure 5), we can observe 
their level of differential expression. In detail, we 
detected the following genes differentially 
expressed and strongly correlated to RNU6-
505P:  
• CYP26A1and ARHGAP18 are up-regulated 
(same as RNU6-505P)  
• TSPAN12, HEY2 and TMEM132A are down-
regulated (opposite to RNU6-505P) 
Table 2: List of genes positively/negatively correlated to RNU6-505P 
Down Regulated Up Regulated 
SYMBOL Pearson Corr. Pearson Sign. SYMBOL Pearson Corr. Pearson Sign. 
HEY2 -0.9368 4.1E-1.0 ZIC4 0.94881 5.9E-11 
TIMP3 -0.9210 3.2E-0.9 CHMP1B 0.94322 1.5E-10 
S100A16 -0.9191 4.0E-0.9 CYP26A1 0.9464 1.7E-10 
ALDOC -0.9184 4.3E-0.9 RNU6-1169P 0.93727 3.9E-10 
CYYR1 -0.9101 1.1E-0.8 ARHGAP18 0.91637 5.5E-0.9 
TSPAN12 -0.8949 4.4E-0.8 TNFRSF11B 0.91431 6.8E-0.9 
KAL1 -0.8874 8.2E-0.8 CHRM3 0.90925 1.2E-0.8 
TMEM132A -0.8798 1.5E-0.7 WDR91 0.90431 1.9E-0.8 
ASTN1 -0.8756 2.0E-0.7 FIGN 0.90248 2.2E-0.8 
C4B -0.7944 1.66E-0.05 ZIC1 0.88082 1.37E-0.07 
   CD36 0.85757 6.77E-0.07 
   MATN2 0.78621 2.38E-0.05 
   FAM46A 0.78182 2.84E-0.05 
   RIMS2 0.76195 5.97E-0.05 
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Figure 5: Top 5 genes strongly correlated to RNU6-505P and differentially expressed 
The Table 3 reports the RF and SVM classifiers 
for the interaction between the RNA sequence of 
RNU6-505P and the proteins encoded by the 
genes in Table 2. Outcomes show that genes 
directly correlated to RNU6-505P have 𝑆𝑉𝑀 <
0.8  , while the range 0.6 < 𝑆𝑉𝑀 < 0.8  is 
identified for those “inversely” correlated, 
suggesting a partitioning between the 2 sets.  
Is the prediction of RNA-protein interactions in 
the case of human the same as other species? The 
Figure 6 shows the SVM classifier in case of 
human, gorilla, chimpanzee and mouse. In 
details, in the case of human we took in 
consideration the SVM values calculated for the 
interaction between RNA6-505P and all 
mentioned proteins (Table 3); considering the 
case of the other species: we calculated the SVM 
value between the RNU6-505P ortholog and the 
ortholog of proteins considered previously 
(Table 3). Results advise that the RNA6-
505P/Proteins interacting could be human 
specific, because in most of case the SVM value 
is higher for human. And also, this analysis hints 
that could be possible to consider the “mouse 
model” to test the real connections between 
RNU6-505P and proteins whose SVM values are 
greater than 0.860 and coincident to the human 
case (C4B, TIMP3, ZIC4, WDR91). It’s 
interesting to note that all of them are well 
expressed in the choroid plexus, while the human 
specific (CYP26A1 and ARHGAP18) are 
respectively strongly expressed in cerebellum and 
ganglion. 
93 
 
 ISSN: 2456-7132  
Available online at Journals.aijr.in 
Differential Expression Analysis on Schizophrenia Dataset Suggests Pseudogene RNU6-505P as under Selective Pressure 
 
 
 
UNIPROT ID RF  SVM  Gene DESC 
Q9UQ26|RIMS2_HUMAN 0.75 0.961 RIMS2 Regulating synaptic membrane exocytosis protein 2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
P0C0L5|CO4B_HUMAN 0.65 0.931 C4B Complement C4-B 
O43174-2|CP26A_HUMAN 0.65 0.924 CYP26A1 Cytochrome P450 26A1 
Q8N9L1|ZIC4_HUMAN 0.6 0.922 ZIC4 Zinc finger protein ZIC 4 
P20309|ACM3_HUMAN 0.65 0.919 CHRM3 Muscarinic acetylcholine receptor M3 
A4D1P6|WDR91_HUMAN 0.65 0.91 WDR91 WD repeat-containing protein 91 
O14525|ASTN1_HUMAN 0.5 0.91 ASTN1 Astrotactin-1 
Q8N392|RHG18_HUMAN 0.6 0.893 ARHGAP18 Rho GTPase-activating protein 18 
P23352|KALM_HUMAN 0.65 0.87 KAL1 Anosmin-1 
Q5HY92|FIGN_HUMAN 0.55 0.863 FIGN Fidgetin 
Q24JP5|T132A_HUMAN 0.75 0.85 TMEM132A Transmembrane protein 132A 
P16671|CD36_HUMAN 0.6 0.839 CD36 Platelet glycoprotein 4 
P35625|TIMP3_HUMAN 0.6 0.78 TIMP3 Metalloproteinase inhibitor 3 
O95859|TSN12_HUMAN 0.55 0.78 TSPAN12 Tetraspanin-12 
O00339|MATN2_HUMAN 0.8 0.769 MATN2 Matrilin-2 
O00300|TR11B_HUMAN 0.65 0.766 TNFRSF11B Tumor necrosis factor receptor superfamily member 
11B 
Q96IP4|FA46A_HUMAN 0.65 0.736 FAM46A Protein FAM46A 
P09972|ALDOC_HUMAN 65 0.73 ALDOC Fructose-bisphosphate aldolase C 
Q7LBR1|CHM1B_HUMAN 0.5 0.726 CHMP1B Charged multivesicular body protein 1b 
Q15915|ZIC1_HUMAN 0.65 0.72 ZIC1 Zinc finger protein ZIC 1 
Q9UBP5|HEY2_HUMAN 0.65 0.676 HEY2 Hairy/enhancer-of-split related with YRPW motif 
protein 2 
Q96FQ6|S10AG_HUMAN 0.45 0.65 S100A16 Protein S100-A16 
Q96J86|CYYR1_HUMAN 0.6 0.56 CYYR1 Cysteine and tyrosine-rich protein 1 
 
3.3 Expression of RNU6-505P into Neuro 
Pathologies 
The diagram reported in Figure 7 points out the 
most important properties about the biological 
function and component for CYP26A1, 
ARHGAP18, TSPAIN12, HEY2 and TMEM32 
genes. In this representation, the link between 
two genes (direct or mediated) shows the existing 
biological correlation and the arrows from 
RNU6-505P stress the possible links to the 
correlated genes. This schema highpoints the 
reasonable engagements that RNU6-505P has in 
many biological functions. 
Another way to figure out the possible functions 
of RNU6-505P is to investigate the identified 
pathologies of its correlated genes. The OMIM 
diagram in Figure 8 depicts the disease network 
of the genes strongly correlated to RNU6-505P. 
As we suspected, most of the diseases are 
generally neurological, while ARHGAP18 is 
directly linked to schizophrenia, confirming again 
our hypothesis of correlation. 
Figure 6: Comparison of RNA-protein interaction prediction 
Table 3: RNA-protein interaction prediction based on sequences. In green the upregulated genes, while in 
grey the downregulated 
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Figure 7: Gene Network Concept of RNU6-505P and its strongly correlated genes that are differentially 
expressed. Blue colour means Positive Correlation, red means Negative Correlation 
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Figure 8: Disease gene network 
 
Figure 9: mRNA expression in normal human tissues for RNU6-505P gene during the prenatal development 
 
Figure 10: mRNA expression of correlated genes 
Figure 9 reports the level of mRNA expression in 
normal tissue for RNU6-505P (Genecards 
website [28]) during the prenatal human brain 
development, while Figure 10 depict the same 
information for its correlated genes. Considering 
that the expression level of mRNA RNU6-505P 
is stronger on brain and cerebellum tissues (Figure 
9) and that we got the same evidence for the 
genes strongly correlated to RNU6-505P from 
prenatal human brain development (Human 
Developmental Biology Resource, 
ENSG00000255112 from Atlas) at the 9th week 
after conception, results suggest that RNU6-
505P could really play a crucial rule in the brain 
development. 
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3.4 Positive Selective Pressure of 
Nucleotides on RNU6-505P (AGA 
site) 
Firstly, we focused on the human evolution using 
his branch like foreground and all others like 
background. Secondly, we have performed the 
same on the chimpanzee case. By the comparison 
of the two evolutionary models, we observe 
(Figure 11) that some regions seem to be under 
positive pressure (peaks), but only someone are 
human specific: TAT, AGA, GCC and ACA (red 
arrows). This result points out that, for some 
reason, the RNU6-505P pseudogene has been 
object of evolution pressure for human. 
 
Figure 11: Selective pressure of the extended region near to RNU6-505P 
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Figure 12: Secondary structure prediction of RNU6-505P with (B)  
and without (A) 1-nucleotide mutation on AGA  
3.5 Mutation Prediction of AGA is Fatal 
for the Structure of RNU6-505P 
What happens to the secondary structure if we 
consider all possible one-nucleotide mutation on 
that regions? The next picture shows the 
prediction of the secondary structure of RNU6-
505P “extended” sequence (345bp) obtained by 
RNAfold program, while the next one depicts the 
predictions of the secondary structures obtained 
mutating the AGA sequence. Amazingly, taking a 
look to the reported predictions (Figure 12), it is 
possible to deduce that mutations on AGA 
nucleotides could be fatal for the RNA structure 
of the sequence. Evidence that sustains our 
hypothesis that RNU6-505P, even if is not a 
protein coding sequence, could have a relevant 
rule in the cerebral development and evolution 
from the apes.  
4 Conclusions 
Pseudogenes have long been considered mere 
remnants of evolution. Only lastly, scientific 
research tends to recognize an important 
regulatory function in the genetic context. This 
work has highlighted how the pseudogene 
RNU6-505P, while not coding for any protein, is 
a potential marker for schizophrenic patients. In 
addition, clustering analysis has shown that 
related genes are involved in neurological 
functions and pathologies, advancing the 
hypothesis that RNU6-505P is engaged in some 
prenatal development of the human brain. 
A B 
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Finally, the evolutionary pressure to which it has 
been subjected and the prediction of the second-
level structure in the case of mutation on a single 
nucleotide, have further emphasized the 
importance that this pseudogene may have had in 
the human evolutionary process. 
5 Declarations 
5.1 Limitations of the Study 
In our opinion here, we present the first case of 
highlighting role of RNU6-505P pseudogene in 
schizophrenia pathogenesis. The study has some 
limitations that can be overcome in future 
studies: 1) low number of schizophrenia cases 
and control samples studied in transcriptome 
analyses; 2) “mouse model” in vitro analysis 
needed to confirm biological significance of our 
findings on correlation of above mentioned up- 
and down-regulated genes expression. There are 
also a number of the most recent studies utilizing 
novel approaches appears showing newly 
discovered candidate genes, risk genes, and 
marker genes for schizophrenia [29-32]. 
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